XML 37 R26.htm IDEA: XBRL DOCUMENT v3.10.0.1
Taxation
9 Months Ended 12 Months Ended
Sep. 30, 2018
Dec. 31, 2017
Taxation [Abstract]    
Taxation

3. Taxation

 

The Group’s income tax expense recognized in the condensed interim consolidated statement of profit or loss is presented as follows:

 

    Nine months ended  
   

September 30,

2018

   

September 30,

2017

 
Deferred income tax expense            
Deferred income tax gain     26,179       24,573  
Total income tax gain     26,179       24,573  

 

The tax effect of taxable temporary differences that give rise to deferred income tax liabilities or to deferred income tax assets as of September 30, 2018 and 2017 is presented as follows:

 

   

September 30,

2018

   

September 30,

2017

 
Deferred Tax liabilities                
Intangible assets     (354,117 )     (349,052 )
Hercules Loan & Warrant     (5,202 )     (53,309 )
Derivatives financial instrument     (19,759 )      
Total     (379,078 )     (402,361 )
Deferred Tax asset                
Net operating loss (NOL)     226,448       230,352  
Total     226,448       230,352  
Deferred Tax, net     (152,630 )     (172,009 )

20. Taxation

 

The Group’s income tax expense recognized in the consolidated statement of profit or loss and other comprehensive loss was as follows:

 

    2017     2016     2015  
Deferred income tax expense     (21,415 )           (32,761 )
Deferred income tax gain     39,188       131,055       32,761  
      17,773       131,055        

 

The Group’s effective income tax expense differed from the expected theoretical amount computed by applying the Group’s applicable weighted average tax rate of 21.7% in 2017 (2016: 21.5%, 2015: 21.9%) as summarized in the following table:

 

    2017     2016     2015  
Reconciliation                  
Loss before income tax     (24,427,247 )     (30,793,306 )     (29,705,063 )
Income tax at statutory tax rates applicable to results in the respective countries     5,311,030       6,629,237       6,493,569  
Effect of unrecognized temporary differences     193,598       (27,072 )     (105,395 )
Effect of unrecognized taxable losses     (5,429,935 )     (6,360,837 )     (6,438,609 )
Effect of previously unrecognized deferred tax asset     39,189       131,055        
Effect of expenses deductible for tax purposes     9,696       2,505        
Effect of expenses not considerable for tax purposes           23,716        
Effect of impact from application of different tax rates     (105,805 )     (267,695 )      
Effect of unrecognized taxable losses in equity           146       50,435  
Income tax gain     17,773       131,055        

 

The tax effect of taxable temporary differences that give rise to deferred income tax liabilities or to deferred income tax assets as of December 31 is presented below:

 

   

December 31,

2017

   

December 31,

2016

 
Deferred Tax Liabilities            
Intangible assets     (349,052 )     (327,637 )
Hercules Loan Facility     (47,477 )     (76,390 )
Total     (396,529 )     (404,027 )

 

   

December 31,

2017

   

December 31,

2016

 
Deferred Tax Assets            
Net operating loss (NOL)     217,720       207,445  
Total     217,720       207,445  
Deferred Tax, net     (178,809 )     (196,582 )

 

Deferred Tax 2017  

Opening

Balance

   

Recognized in

Profit or Loss

   

Recognized

in Equity

   

Closing

Balance

 
Intangible assets     (327,637 )     (21,415 )           (349,052 )
Hercules Loan Facility     (76,390 )     28,913           —       (47,477 )
Net operating loss (NOL)     207,445       10,275             217,720  
Total     (196,582 )     17,773             (178,809 )

 

Deferred Tax 2016  

Opening

Balance

   

Recognized in

Profit or Loss

   

Recognized

in Equity

   

Closing

Balance

 
Intangible assets     (327,637 )               —       (327,637 )
Hercules Loan Facility           (76,390 )           (76,390 )
Net operating loss (NOL)           207,445             207,445  
Total     (327,637 )     131,055             (196,582 )

 

As of December 31, 2017, the Group had total gross tax loss carry forwards amounting to CHF 142 million (2016: CHF 115.4 million), of which CHF 140.9 million related to Auris Medical AG, Auris Medical Holding AG and Otolanum AG in Switzerland and CHF 1.1 million to Auris Medical Inc. in the United States (2016: CHF 114.3 million for Auris Medical AG and Otolanum AG and CHF 1.1 million for Auris Medical Inc.).

 

The Group’s tax loss carry-forwards with their expiry dates are as follows:

 

   

December 31,

2017

   

December 31,

2016

 
Within 1 year     1,754,398       1,859,601  
Between 1 and 3 years     31,089,191       9,928,391  
Between 3 and 7 years     108,055,089       102,542,641  
More than 7 years     1,072,260       1,087,543  
Total     141,970,938       115,418,176  

 

The tax effect of the major unrecognized temporary differences and loss carry-forwards is presented in the table below:

 

   

December 31,

2017

   

December 31,

2016

 
Deductible temporary differences                
Employee benefit plan     433,816       450,227  
Stock option plans     400,764        
Total potential tax assets     834,580       450,227  
Taxable unrecognized temporary differences                
Property and equipment            
Total unrecognized potential tax liabilities            
Offsetting potential tax liabilities with potential tax assets            
Net potential tax assets from temporary differences not recognized     834,580       450,227  
Potential tax assets from loss carry-forwards not recognized     29,959,963       25,082,968  
Total potential tax assets from loss carry-forwards and temporary differences not recognized     30,794,543       25,533,195